Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7922183 | 0.89 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBELANE | |
| SCHEMBL15064301 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHR | |
| SCHEMBL10064103 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHR | |
| SCHEMBL13900356 | 0.78 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL7920391 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL6560036 | 0.75 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL28557088 | 0.75 | TSHR (0.35) | ALDH1A1TSHR | |
| SCHEMBL13900353 | 0.75 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBELANE | |
| SCHEMBL3674221 | 0.75 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBELANE | |
| SCHEMBL47313 | 0.75 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4340532-A | CURABLE ORTHODONTIC COMPOSITION | LEE PHARMACEUTICALS, INC. (US) | 1982-07-20 | — | — | US | claimed |
| US-12583874-B2 | Compound, anti-reflection film comprising same, and display device | SAMSUNG SDI CO., LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| US-20250362433-A1 | COMPOUND, ANTIREFLECTION FILM COMPRISING THE SAME AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2025-11-27 | — | — | US | disclosed |
| US-12359084-B2 | Ink composition, layer using same, and display device | SAMSUNG SDI CO., LTD. (KR) | 2025-07-15 | — | — | US | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| US-20240352270-A1 | INK COMPOSITION, LAYER USING SAME, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2024-10-24 | — | — | US | disclosed |
| US-20240310726-A1 | PHOTORESIST PROCESS | Helio Display Materials Limited (GB) | 2024-09-19 | — | — | US | disclosed |
| US-20240182728-A1 | INK COMPOSITION, LAYER USING SAME, AND ELECTROPHORESIS DEVICE AND DISPLAY DEVICE COMPRISING SAME | SAMSUNG SDI CO LTD (KR) | 2024-06-06 | — | — | US | disclosed |
| US-20240166898-A1 | INK COMPOSITION, LAYER AND DISPLAY DEVICE USING SAME | SAMSUNG SDI CO., LTD. (KR) | 2024-05-23 | — | — | US | disclosed |
| EP-4363930-A1 | PHOTORESIST PROCESS | Helio Display Materials Limited (GB) | 2024-05-08 | — | — | EP | disclosed |
| WO-2002073720-A2 | BINDER COMPOSITION | ATOFINA (FR) | 2002-09-19 | — | — | WO | disclosed |
| US-5580819-A | COATING SUBSTRATE WITH MIXTURE OF PRODUCTS OF ACID-CATALYZED HYDROLYSIS AND CONDENSATION OF SILANE MONOMERS, WATER AND COMPATIBLE FILM FORMING POLYMERS, CURING, THEN TREATING THE COATING WITH AQUEOUS INORGANIC ELECTROLYTE FOR POROSITY | PPG INDUSTRIES, INC. (US) | 1996-12-03 | — | — | US | disclosed |
| US-4871785-A | CROSSLINKED POLYOXYETHYLENE GLYCOL | FROIX MICHAEL (US) | 1989-10-03 | — | — | US | disclosed |
| US-4790881-A | CELLULOSE DERIVATIVES, POLYVINYLPYRROLIDINE, GUM ARABIC; CAPSULES | WARNER-LAMBERT COMPANY (US) | 1988-12-13 | — | — | US | disclosed |
| US-4738817-A | HEATING, HOMOGENIZING, INJECTING, COOLING, EJECTING | WARNER-LAMBERT COMPANY (US) | 1988-04-19 | — | — | US | disclosed |
| EP-0090600-B1 | METHOD FOR MOLDING CAPSULES | WARNER-LAMBERT COMPANY (US) | 1987-07-22 | — | — | EP | disclosed |
| US-4655840-A | CAPSULES | WARNER-LAMBERT COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0092908-A2 | Hydrophilic polymer composition for injection molding | WARNER-LAMBERT COMPANY (US) | 1983-11-02 | — | — | EP | disclosed |
| US-4340529-A | CURABLE ACRYLATE PRIMER | LEE PHARMACEUTICALS, INC. (US) | 1982-07-20 | — | — | US | disclosed |
| US-4264493-A | Natural protein polymer hydrogels | ESSILOR INTERNATIONAL(ESSILOR) (FR) | 1981-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583874-B2 | Compound, anti-reflection film comprising same, and display device | KISS1R, CCKAR, TACR2 | ALDH1A1 952/4885TSHR 83/4885THRB 1300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.